For the hundreds of thousands of people who undergo sphincter-preserving surgery for rectal cancer each year, saving the ...
A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific ...
The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for ...
When someone is diagnosed with colorectal cancer—which includes both colon and rectal cancers—many people immediately think "surgery." And it's true that surgery plays a central role in treatment for ...
Add Yahoo as a preferred source to see more of our stories on Google. Zoe Gardner-Lawson, pictured before and after bowel cancer surgery. (SWNS) Zoe Gardner-Lawson, 36, an HR manager and mum-of-three ...
Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of ...
Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of ...
Genentech, part of Roche Group (USOTC:RHHBY), has received FDA approval for Tecentriq in combination with chemotherapy for a ...
The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...
Woman survived colon cancer three times after being diagnosed in her teens, 20s and 30s. She shares her symptoms and how Lynch syndrome raises her cancer risk.
Abdominal pain or changes in bowel habits should not be ignored simply because someone is young. They could be signs of a ...